BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21469950)

  • 1. Quantification of dermal and transdermal delivery of meloxicam gels in rabbits.
    Patel M; Joshi A; Hassanzadeth H; Juluru R; Stagni G
    Drug Dev Ind Pharm; 2011 May; 37(5):613-7. PubMed ID: 21469950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of penetration enhancers on in vitro permeability of meloxicam gels.
    Jantharaprapap R; Stagni G
    Int J Pharm; 2007 Oct; 343(1-2):26-33. PubMed ID: 17531412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation of meloxicam gel for topical application: In vitro and in vivo evaluation.
    Bachhav YG; Patravale VB
    Acta Pharm; 2010 Jun; 60(2):153-63. PubMed ID: 21134852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ion-pair formation combined with a penetration enhancer as a dual strategy to improve the transdermal delivery of meloxicam.
    Jiang Q; Wang J; Ma P; Liu C; Sun M; Sun Y; He Z
    Drug Deliv Transl Res; 2018 Feb; 8(1):64-72. PubMed ID: 29181834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Mar; 92(6-7):383-92. PubMed ID: 23353874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation.
    Khurana S; Jain NK; Bedi PM
    Drug Dev Ind Pharm; 2015; 41(8):1368-75. PubMed ID: 25151872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam.
    Khurana S; Bedi PM; Jain NK
    Chem Phys Lipids; 2013; 175-176():65-72. PubMed ID: 23994283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Percutaneous absorption of meloxicam patches in hairless mouse].
    Gao QZ; Yang LY; Ding PT; He ZG
    Yao Xue Xue Bao; 2007 Dec; 42(12):1320-2. PubMed ID: 18338648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation optimization of meloxicam sodium gel using response surface methodology.
    Chang JS; Huang YB; Hou SS; Wang RJ; Wu PC; Tsai YH
    Int J Pharm; 2007 Jun; 338(1-2):48-54. PubMed ID: 17360134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation.
    Narishetty ST; Panchagnula R
    Biopharm Drug Dispos; 2004 Jan; 25(1):9-20. PubMed ID: 14716748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous Penetration-Enhancing Effect of Menthol: Calcium Involvement.
    Joshi A; Joshi A; Patel H; Ponnoth D; Stagni G
    J Pharm Sci; 2017 Jul; 106(7):1923-1932. PubMed ID: 28400197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meloxicam carbopol-based gels: characterization and evaluation.
    Sareen R; Kumar S; Gupta GD
    Curr Drug Deliv; 2011 Jul; 8(4):407-15. PubMed ID: 21453256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of ion-pairing and chemical enhancers on the transdermal delivery of meloxicam.
    Zhang JY; Fang L; Tan Z; Wu J; He ZG
    Drug Dev Ind Pharm; 2009 Jun; 35(6):663-70. PubMed ID: 19259875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam.
    Khalil RM; Abd-Elbary A; Kassem MA; Ghorab MM; Basha M
    Pharm Dev Technol; 2014 May; 19(3):304-14. PubMed ID: 23528038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions.
    Dehghani H; Taheri A; Homayouni A
    Curr Drug Deliv; 2017; 14(5):709-717. PubMed ID: 27142108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation of diazepam transdermal gel and its bioavailability].
    Xu Q; Zan YP; Gao CH
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 41(4):441-4, 463. PubMed ID: 22927081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic enhancement of papaverine transdermal gel for erectile dysfunction.
    Wen MM; El-Kamel AH; Khalil SA
    Drug Dev Ind Pharm; 2012 Aug; 38(8):912-22. PubMed ID: 22080854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of mixed-solvent and terpenes on percutaneous absorption of meloxicam gel.
    Chang JS; Tsai YH; Wu PC; Huang YB
    Drug Dev Ind Pharm; 2007 Sep; 33(9):984-9. PubMed ID: 17891585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of risperidone from gels across porcine skin in vitro and in vivo in rabbits.
    Ning Y; Chen X; Yu Z; Liang W; Li F
    Pak J Pharm Sci; 2018 May; 31(3):885-891. PubMed ID: 29716869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.